Skip to main content

Table 1 Definitions of dysglycaemia according to WHO and ADA

From: Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology

Test/diagnose Cut off level
HbA1c % DCCT mmol/mol IFCC
High risk HbA1c 5.7–6.4 39–47
Diabetes ≥ 6.5 ≥ 48
Plasma glucose mmol/l mg/dl
Impaired fasting glucose
 Fasting 6.1–6.9 110–125
 2 h postload < 11.0 < 200
Impaired glucose tolerance
 Fasting < 7.0 < 126
 2 h postload ≥ 7.8–11.0 ≥ 140–199
Diabetes
 Fasting > 7.0 > 126
 2 h postload ≥ 11.1 ≥ 200